FWGIX | MWEIX | FWGIX / MWEIX | |
Total Expense Ratio | 0.41 | 0.90 | 46% |
Annual Report Gross Expense Ratio | 0.41 | 0.93 | 44% |
Fund Existence | 8 years | 28 years | - |
Gain YTD | 9.196 | 6.260 | 147% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 131B | 2.18B | 6,001% |
Annual Yield % from dividends | 1.85 | 0.95 | 195% |
Returns for 1 year | 6.71 | -3.53 | -190% |
Returns for 3 years | 45.29 | 3.52 | 1,285% |
Returns for 5 years | 53.53 | 11.55 | 463% |
Returns for 10 years | N/A | 33.74 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AZNAX | 11.06 | -0.07 | -0.63% |
Virtus Income & Growth A | |||
FBTIX | 29.15 | -0.19 | -0.65% |
Fidelity Advisor Biotechnology I | |||
MSBQX | 11.94 | -0.15 | -1.24% |
Morgan Stanley American Resilience R6 | |||
NAIGX | 32.82 | -0.43 | -1.29% |
Nuveen International Value A | |||
MNHCX | 25.58 | -0.40 | -1.54% |
Manning & Napier Pro-Blend Max Term L |